...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer

Toinv, (to your last comment)...I don't know but would you not prefer a large cash deal with HL similar to the one with RVX. This would not prevent the collaboration with Pfizer.

Zenith needs cash to stand on its own 2 feet to survive. (IMO)

 

Koo 

Share
New Message
Please login to post a reply